PI Industries Limited — Updates, 12-08-2025: Press Release

PI Industries reported Q1 FY26 consolidated revenue of ₹1,900.5 Cr (-8% YoY), PAT of ₹400 Cr (-11% YoY), and EBITDA of ₹521.9 Cr (27% margin). Domestic agri sales grew 6%, though biologicals faced an industry-wide sales suspension, declining 38%. Agchem exports dipped 14%, but new products surged 46%. The Pharma segment showed a strong rebound, growing 186% to ₹72.3 Cr. India's first discovery molecule, PIOXANILIPROLE, was filed for registration. Capex for the quarter was ₹220.7 Cr, with operating cash flow at ₹216.8 Cr, maintaining a robust net cash position of ₹4,155.4 Cr. Management anticipates H2 acceleration, targeting single-digit revenue growth with sustained margins for FY26.